In the New Uzbekistan Development Strategy for 2022-2026 such important tasks as «Increasing the share of domestically produced medicines and medical products to 80 percent... » were noted. In this regard, it is important to expand the range of medicines and dietary supplements based on medicinal plants that meet the requirements of modern quality standards, harmonise them under the provisions of international regulatory documents, and introduce them into domestic pharmaceutical production. As a result of reforms over the past five years, the country has established the political-legal, socio-economic, and scientific-educational foundations necessary for building New Uzbekistan, including the adoption of ten Resolutions and Decrees of the President of the Republic of Uzbekistan in the field of cultivation and processing of medicinal plants.
To create favorable conditions for the active attraction of foreign and domestic investments to the implementation of investment projects aimed at developing the pharmaceutical industry of the Republic, enhancing domestic production, taking into account the unique conditions for cultivating medicinal plant raw materials, organizing its deep processing and production of pharmaceutical products with high added value, as well as the comprehensive and efficient use of the production and resource potential of the Republic of Uzbekistan, the following Decrees and Resolutions of the President of the Republic of Uzbekistan and the Cabinet of Ministers of the Republic of Uzbekistan were issued: «On the creation of free economic zones «Nukus-Pharm», «Zomin-Pharm», «Kosonsoy-Pharm», «Sirdaryo-Pharm» «Boysun-Pharm», «Bustonlik-Pharm», «Parkent-Pharm» №UP-5032 dated May 3, 2017; «On measures for further development of production and industrial processing of licorice and other medicinal plants in the Republic of Uzbekistan» №63, dated January 27, 2018; «On additional measures for the efficient organization of production and industrial processing of licorice and other medicinal plants» № 138 dated February 15, 2019; «On measures to create ferula plantations in the republic, increase the volume of processing of its raw materials and export» №3617 dated March 20, 2018; «On additional measures for the development of traditional medicine in the Republic of Uzbekistan» № 4668, dated April 10, 2020; «On measures for the protection, cultural cultivation, processing of wild medicinal plants and the rational use of available resources» №PP-4670 dated, April 10, 2020; «On measures to expand the scope of scientific research on the cultivation and processing of medicinal plants, the development and establishment of their seed production» №4901 dated November 26, 2020; «On additional measures to stimulate the development and industrialization of ferula cultivation in the republic» №UP-116 dated April 27, 2022; «On measures for the organization of cultivated growing, processing, and widespread use of medicinal plants in treatment» №PP-251 dated May 20, 2022; «On measures to create added value chain through the efficient use of raw materials and support for the processing of medicinal plants» №UP-139 dated May 20, 2022. These regulatory documents provide for the organization of plantations for the cultivation and procurement of several medicinal export-oriented plants, conducting laboratory and scientific research for the development of drugs based on these plants, gradual inclusion of proven medicinal plants into medical care standards and protocols, as well as the promotion of medicinal plants among the population and doctors. The documents also provide for the creation of departments in all state medical educational institutions focused on training in the use of medicinal plants and traditional medicine. Additionally, they include the organization of retraining and specialization programs for doctors in the treatment by using medicinal plants and traditional medicine methods, as well as advanced training for therapists, general practitioners, and family doctors. Furthermore, the establishment of traditional medicine offices and herbal bars in state medical institutions, in particular in each clinic, for the treatment using medicinal plants is also planned.
In compliance with the above-mentioned decrees and resolutions, and by the decision of the Ministry of Health of the Republic of Uzbekistan, the Uzbek-Indian Joint Venture «Nova Pharm» has taken the initiative to produce ayurvedic medicines based on medicinal plants that grow in our republic. The company has already developed the «Boysun-Pharm» land plot for the cultivation of various medicinal plants, including turmeric and fenugreek, which were imported from India and are now being used as raw materials for Ayurvedic medicines.
Ayurveda is one of the most ancient sciences, originating in India several thousand years ago. Although some consider Ayurveda to be a "pseudoscience," Ayurveda has powerful tools to address the root causes of illness while simultaneously alleviating symptoms and improving quality of life during the healing process.
Ayurvedic medicine involves a comprehensive approach that includes proper nutrition, massage, breathing exercises, and taking natural Ayurvedic preparations based on herbs and minerals.
Ayurvedic complexes are medicinal formulas of natural origin that have been tested for thousands of years.
In India, healing plants are a valuable source for creating various organic medicines and complexes. Plant components make up the majority of all cosmetic and medicinal products used in medical Ayurveda. Therefore, the best Ayurvedic clinics create personalized remedies for their patients, tailored to produce specific effects on the body. Modern laboratory tests demonstrate the possibility of developing effective medications based on some natural substances and medicinal plants used in Ayurveda. Research is also being conducted on the effectiveness of Ayurvedic preparations, but since all the complexes are made from plant materials, it is difficult to standardize them. In Uzbekistan, Ayurvedic medications of the "Nova Pharm" company are registered as dietary supplements, although some of them have successfully undergone clinical trials in several clinics within our republic. The Uzbek-Indian Joint Venture «Nova Pharm» currently produces several Ayurvedic complexes that are successfully sold in the pharmaceutical market of Uzbekistan.
Today, the line of Ayurvedic complexes includes several highly relevant products: «Fenugreek» сapsules, «Cardioclear», «Curcumin», «Liv-Protect Hepa+», «Revmalin», «VisBest», «Novaston», «Hope», as well as syrups such as «Novaston», «Herbomix Broncho», «Ayur-G».
The medicinal plants used in Ayurvedic complexes of «Nova Pharm» company have proven their effectiveness over centuries in treating various illnesses. These include ginger, fenugreek, tulsi, turmeric, licorice, ferula, tribulus and other herbs. In addition, these plants are consistently present in the form of spices in Indians' daily food, helping to address enzymatic, mineral, and vitamin deficiencies, improve digestion, and have a general strengthening effect.
Ayurvedic complexes of «Nova Pharm» company are modern, innovative formulas of natural plant origin with high pharmacological efficacy, distinguished by their safety and accessibility for the general population.